Authors
Qingqin Xu, Junjie Fu, Li Zhang, Ying Zhang, Xiyuan Chen, Guangsheng Ci, Hong Song, Lin Yu, Shi Chen, Hemu Chen
Published in
Neural regeneration research. Nov 17, 2026. Epub Nov 17, 2026.
Abstract
Functional recovery after incomplete spinal cord injury remains limited largely because injured corticospinal pathways have insufficient capacity for structural remodeling and reconnection. Repetitive transcranial magnetic stimulation targeting the primary motor cortex (M1) can modulate cortical excitability, but whether it drives corticospinal tract remodeling after spinal cord injury and how neurotrophic mechanisms contribute to this process remain poorly understood. Glial cell line-derived neurotrophic factor-related signaling may provide a biological link between cortical stimulation and regenerative responses within the injured nervous system. A multilevel translational design integrating transcriptomic analysis, animal experiments and exploratory clinical evaluation was applied. Public spinal cord injury transcriptomic datasets were integrated to identify shared repair-associated genes and pathways. Bilateral M1-targeted repetitive transcranial magnetic stimulation was administered in a T10 incomplete spinal cord injury rat model, with or without systemic anti-glial cell line-derived neurotrophic factor antibody treatment. Behavioral, electrophysiological, histological and molecular analyses were performed to evaluate functional recovery, corticospinal tract remodeling and glial cell line-derived neurotrophic factor-related signaling. Finally, an exploratory randomized controlled trial was conducted to assess functional, electrophysiological and serum biomarker responses to repetitive transcranial magnetic stimulation in patients with incomplete spinal cord injury. Integrated transcriptomic analysis identified 51 shared differentially expressed genes linked to neurotrophic regulation, neural remodeling and PI3K/AKT/mTOR signaling. In rats with incomplete spinal cord injury, bilateral M1-targeted repetitive transcranial magnetic stimulation improved locomotor recovery and corticospinal function, promoted corticospinal tract remodeling, and modulated a glial cell line-derived neurotrophic factor-associated PTEN/PI3K/AKT/mTOR signaling profile, whereas anti-glial cell line-derived neurotrophic factor antibody treatment partially attenuated these repetitive transcranial magnetic stimulation-associated effects. Spinal RNA sequencing further revealed enrichment of pathways related to axonal growth and synaptic function. Clinically, real repetitive transcranial magnetic stimulation was associated with superior functional and electrophysiological outcomes and higher serum levels of neuroplasticity-associated biomarkers than sham stimulation. In summary, bilateral M1-targeted repetitive transcranial magnetic stimulation was associated with corticospinal tract remodeling and functional recovery after incomplete spinal cord injury. Preclinical findings support a contributory role of glial cell line-derived neurotrophic factor-associated PTEN/PI3K/AKT/mTOR signaling in repetitive transcranial magnetic stimulation-induced neural repair, whereas the exploratory clinical results provide preliminary translational evidence without demonstrating the same molecular mechanism in humans.
PMID:
43045661
Bibliographic data and abstract were imported from PubMed on 18 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 4
- Comments 0